Sophia Wakefield | Medicine and Health Sciences | Best Researcher Award

Dr. Sophia Wakefield | Medicine and Health Sciences | Best Researcher Award

Doctor University of Leeds United Kingdom

Dr. Sophia Wakefield, born in 1999, is a dynamic medical professional currently serving as a Hospital Doctor under Health Education Yorkshire and Humber. She has a strong foundation in trauma and orthopaedics, with a passion for advancing patient care and medical research. Her journey in medicine is marked by academic excellence and a commitment to clinical and educational development.

Profile

Scopus

Education 🎓

  • Master of Research in Medicine (Distinction) – University of Leeds (Sept 2023 – Sept 2024)
  • Postgraduate Certificate in Medical Education (Distinction) – University of Leeds (Sept 2023 – June 2024)
  • MBBCh – Cardiff University (Sept 2017 – July 2023)
  • BSc in Clinical Sports Science (First Class Honours) – Cardiff University (Sept 2021 – June 2022)

Experience 🩺

Dr. Wakefield has accumulated valuable clinical experience in trauma and orthopaedics, contributing to patient care and mentoring peers. She actively participates in conferences and research initiatives, showcasing her expertise through numerous publications, presentations, and leadership roles.

Research Interests 🔬

Dr. Wakefield is deeply interested in trauma and orthopaedics, specifically the management of fractures, surgical innovation, and improving patient outcomes. Her focus extends to addressing sexual and urinary dysfunction post-fractures and advancing techniques for bone defect management.

Awards 🏆

  • Second Place Oral Presentation – RCSEd Foundation Trainees Surgical Society National Conference (2024)
  • £6k Funding Grant – Leeds Hospitals Charity (2024)

Publications Top Notes: 📚

Wakefield, S.M., Kanakaris, N.K., & Giannoudis, P.V. (2025). Sexual and Urinary Dysfunction Following Isolated Acetabulum Fractures: A Systematic Review of the Literature. J Clin Med, 1, 230. Read here.
Cited by: 5 articles

Watson, P., Hanna, D., Wakefield, S.M., et al. (2024). Undergraduate rheumatology teaching in the UK: a survey of current practice by teachers and students. Rheumatology Advances in Practice, 8(4), rkae112. Read here.
Cited by: 12 articles

Wakefield, S.M., Rodham, P.L., & Giannoudis, P.V. (2024). The management of intertrochanteric hip fractures: an update. Orthopaedics and Trauma, 38(2), 70-77. Read here.
Cited by: 8 articles

Wakefield, S.M., Papakostidis, C., et al. (2024). Distraction osteogenesis vs. induced membrane technique for infected tibial non-unions: a systematic review and meta-analysis. Eur J Trauma Emerg Surg, 50(3), 705–721. Read here.
Cited by: 15 articles

Kotsarinis, G., Wakefield, S.M., et al. (2023). Stabilization of Tibial Fractures at Risk of Complications with the Bactiguard Intramedullary Nail. J Orthop Trauma, 37(11S), S12–S17. Read here.
Cited by: 7 articles

Kotsarinis, G., Mauffrey, O., Wakefield, S.M., et al. (2023). Neglected pelvic fragility fracture managed with unilateral triangular osteosynthesis. Trauma Case Reports, 48. Read here.
Cited by: 4 articles

Wakefield, S.M., Giannoudis, V.P., & Giannoudis, P.V. (2023). Clavicular bone defects managed with free vascularised fibular grafting: evidence to date. Eur J Orthop Surg Traumatol. Read here.
Cited by: 9 articles

Tebby, J., Giannoudis, V.P., Wakefield, S.M., et al. (2023). Do Patients with Diabetes Mellitus and Polytrauma Continue to Have Worse Outcomes?. J Clin Med, 12(10), 3423. Read here.
Cited by: 6 articles

Wakefield, S.M., & Giannoudis, P.V. (2023). Rare Bi-focal Presentation of Avascular Necrosis of the Femoral Head. Cureus, 15(3), e36423. Read here.
Cited by: 5 articles

Wakefield, S.M., Giannoudis, V., & Giannoudis, P.V. (2023). Reconstruction of a neglected hyperextension-bicondylar tibial plateau fracture 9 months after original injury. Trauma Case Reports, 45. Read here.
Cited by: 4 articles

Wakefield, S.M., Giannoudis, V., Messori, M., et al. (2022). Atypical APC-1 pelvic fracture with instability: successful management with pubic symphysis fusion. BMJ Case Reports, 15(12), e252473. Read here.
Cited by: 3 articles

Wakefield, R.J., Smith, K., Wakefield, S.M., et al. (2021). Tendon paratenon involvement in gout: an ultrasound feature of tendinous gout?. Joint Bone Spine, 88(1), 105051. Read here.
Cited by: 10 articles

Jan Vorwerk | Medicine and Health Sciences | Young Scientist Award

Dr. Jan Vorwerk | Medicine and Health Sciences | Young Scientist Award

Resident Physician University Cancer Center Schleswig-Holstein (UCCSH) Germany

Dr. Jan Vorwerk is a distinguished medical researcher and clinician currently serving as a resident physician and clinician scientist at the Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), Germany. With a summa cum laude distinction for his medical doctorate and over five years of advanced medical training across Germany, Canada, and Switzerland, Dr. Vorwerk has made remarkable contributions to hematology and oncology research, particularly in acute myeloid leukemia (AML).

Profile

Scopus

Education 🎓

Dr. Vorwerk completed his Medical Doctorate at the University of Münster, with a groundbreaking thesis on the role of GFI1-36N polymorphism in DNA repair and AML therapy, earning summa cum laude honors. He is also a proud alumnus of the University of Zürich and McMaster University. His rigorous academic journey includes first-class grades in multiple state exams and prestigious scholarships from organizations like the German Academic Scholarship Foundation.

Experience 🏥

Dr. Vorwerk’s professional journey includes significant roles as a scholar at the Jürgen Manchot Foundation and the Interdisciplinary Center for Clinical Research Münster. Currently, he is at the forefront of clinical and molecular research in oncology as a resident physician at UCCSH, where he integrates cutting-edge therapies with patient care.

Research Interests 🔬

Dr. Vorwerk specializes in molecular hematology and oncology, focusing on the genetic and metabolic underpinnings of acute myeloid leukemia (AML). His research explores polymorphisms affecting DNA repair, mitochondrial function, and innovative therapeutic targets like CDK4/6 inhibition in leukemia and multiple myeloma.

Awards 🏆

Dr. Vorwerk has been recognized with numerous accolades, including the “Anne Frank Ambassador Award” for academic excellence and community leadership, the “Abitur Graduate Prize” from North Rhine-Westphalia, and scientific honors like the “Young People’s Award” and multiple international science fair prizes.

Publications Top Notes: 📚

Dr. Vorwerk has authored several impactful publications:

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition. Front Oncol. 2022;12:903691.

Germline single-nucleotide polymorphism GFI1-36N causes alterations in mitochondrial metabolism and leads to increased ROS-mediated DNA damage in AML. Biomedicines. 2025;13:107.

Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to therapy. Blood. 2023;142(25):2175-2191.